{"product_id":"tesamorelin-peptide","title":"Tesamorelin Peptide | Growth Hormone Research","description":"\u003ch3 data-end=\"629\" data-start=\"555\"\u003eMetabolic Regulation, Visceral Adiposity \u0026amp; Endocrine Signaling Studies\u003c\/h3\u003e\n\u003cp data-end=\"759\" data-start=\"631\"\u003e\u003cstrong data-end=\"644\" data-start=\"631\"\u003eCategory:\u003c\/strong\u003e\u003cbr data-end=\"647\" data-start=\"644\"\u003eEndocrinology • Metabolic Research • Body Composition • GH Axis Modulation\u003c\/p\u003e\n\u003cp data-end=\"759\" data-start=\"631\"\u003e \u003c\/p\u003e\n\u003ch2 data-end=\"795\" data-start=\"766\"\u003e\u003cstrong data-end=\"795\" data-start=\"769\"\u003eWhat Researchers Study\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp data-end=\"989\" data-start=\"796\"\u003eTesamorelin is a \u003cstrong data-end=\"876\" data-start=\"813\"\u003esynthetic analog of Growth Hormone–Releasing Hormone (GHRH)\u003c\/strong\u003e consisting of the first 29 amino acids of native GHRH with a stabilizing \u003cstrong data-end=\"988\" data-start=\"950\"\u003etrans-3-hexenoic acid modification\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp data-end=\"1032\" data-start=\"991\"\u003eResearchers study Tesamorelin because it:\u003c\/p\u003e\n\u003cul data-end=\"1338\" data-start=\"1033\"\u003e\n\u003cli data-end=\"1099\" data-start=\"1033\"\u003e\n\u003cp data-end=\"1099\" data-start=\"1035\"\u003eStimulates \u003cstrong data-end=\"1099\" data-start=\"1046\"\u003eendogenous, pulsatile growth hormone (GH) release\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1138\" data-start=\"1100\"\u003e\n\u003cp data-end=\"1138\" data-start=\"1102\"\u003ePreserves \u003cstrong data-end=\"1138\" data-start=\"1112\"\u003ephysiologic GH rhythms\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1215\" data-start=\"1139\"\u003e\n\u003cp data-end=\"1215\" data-start=\"1141\"\u003eElevates \u003cstrong data-end=\"1170\" data-start=\"1150\"\u003eIGF-1 indirectly\u003c\/strong\u003e, rather than forcing supraphysiologic levels\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1268\" data-start=\"1216\"\u003e\n\u003cp data-end=\"1268\" data-start=\"1218\"\u003ePreferentially targets \u003cstrong data-end=\"1268\" data-start=\"1241\"\u003evisceral adipose tissue\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1338\" data-start=\"1269\"\u003e\n\u003cp data-end=\"1338\" data-start=\"1271\"\u003eMinimizes proliferative risks associated with exogenous GH exposure\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"1427\" data-start=\"1340\"\u003eTesamorelin is best understood as a \u003cstrong data-end=\"1397\" data-start=\"1376\"\u003eGH-axis regulator\u003c\/strong\u003e, not a growth hormone itself.\u003c\/p\u003e\n\u003cp data-end=\"1427\" data-start=\"1340\"\u003e \u003c\/p\u003e\n\u003ch2 data-end=\"1472\" data-start=\"1434\"\u003e\u003cstrong data-end=\"1472\" data-start=\"1437\"\u003ePrimary Signal Pathways Studied\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cul data-end=\"1704\" data-start=\"1474\"\u003e\n\u003cli data-end=\"1525\" data-start=\"1474\"\u003e\n\u003cp data-end=\"1525\" data-start=\"1476\"\u003e\u003cstrong data-end=\"1525\" data-start=\"1476\"\u003eGHRH receptor activation (anterior pituitary)\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1554\" data-start=\"1526\"\u003e\n\u003cp data-end=\"1554\" data-start=\"1528\"\u003e\u003cstrong data-end=\"1554\" data-start=\"1528\"\u003ePulsatile GH secretion\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1584\" data-start=\"1555\"\u003e\n\u003cp data-end=\"1584\" data-start=\"1557\"\u003e\u003cstrong data-end=\"1584\" data-start=\"1557\"\u003eHepatic IGF-1 signaling\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1617\" data-start=\"1585\"\u003e\n\u003cp data-end=\"1617\" data-start=\"1587\"\u003e\u003cstrong data-end=\"1617\" data-start=\"1587\"\u003eVisceral adipose lipolysis\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1654\" data-start=\"1618\"\u003e\n\u003cp data-end=\"1654\" data-start=\"1620\"\u003e\u003cstrong data-end=\"1654\" data-start=\"1620\"\u003eInsulin sensitivity modulation\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1704\" data-start=\"1655\"\u003e\n\u003cp data-end=\"1704\" data-start=\"1657\"\u003e\u003cstrong data-end=\"1704\" data-start=\"1657\"\u003eLipid metabolism and hepatic fat regulation\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch2 data-end=\"1746\" data-start=\"1711\"\u003e\u003cstrong data-end=\"1746\" data-start=\"1714\"\u003eWhy This Molecule Is Studied\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp data-end=\"1900\" data-start=\"1747\"\u003eUnlike direct GH administration—which creates continuous exposure and non-physiologic signaling—Tesamorelin \u003cstrong data-end=\"1899\" data-start=\"1855\"\u003erestores upstream control of the GH axis\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp data-end=\"1947\" data-start=\"1902\"\u003eThis makes it uniquely valuable for studying:\u003c\/p\u003e\n\u003cul data-end=\"2095\" data-start=\"1948\"\u003e\n\u003cli data-end=\"1970\" data-start=\"1948\"\u003e\n\u003cp data-end=\"1970\" data-start=\"1950\"\u003eVisceral fat biology\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1991\" data-start=\"1971\"\u003e\n\u003cp data-end=\"1991\" data-start=\"1973\"\u003eMetabolic syndrome\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2012\" data-start=\"1992\"\u003e\n\u003cp data-end=\"2012\" data-start=\"1994\"\u003eLipid partitioning\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2037\" data-start=\"2013\"\u003e\n\u003cp data-end=\"2037\" data-start=\"2015\"\u003eAge-related GH decline\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2095\" data-start=\"2038\"\u003e\n\u003cp data-end=\"2095\" data-start=\"2040\"\u003eGH–IGF signaling without excessive tissue proliferation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"2205\" data-start=\"2097\"\u003eTesamorelin allows researchers to observe \u003cstrong data-end=\"2204\" data-start=\"2139\"\u003emetabolic effects without overriding endocrine feedback loops\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp data-end=\"2205\" data-start=\"2097\"\u003e \u003c\/p\u003e\n\u003ch2 data-end=\"2239\" data-start=\"2212\"\u003e\u003cstrong data-end=\"2239\" data-start=\"2215\"\u003eMechanistic Overview\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp data-end=\"2438\" data-start=\"2240\"\u003eTesamorelin binds GHRH receptors in the anterior pituitary, stimulating \u003cstrong data-end=\"2333\" data-start=\"2312\"\u003enatural GH pulses\u003c\/strong\u003e. These pulses then drive downstream \u003cstrong data-end=\"2390\" data-start=\"2370\"\u003eIGF-1 production\u003c\/strong\u003e, lipid mobilization, and metabolic adaptations.\u003c\/p\u003e\n\u003cp data-end=\"2489\" data-start=\"2440\"\u003eKey outcomes observed in research models include:\u003c\/p\u003e\n\u003cul data-end=\"2682\" data-start=\"2490\"\u003e\n\u003cli data-end=\"2553\" data-start=\"2490\"\u003e\n\u003cp data-end=\"2553\" data-start=\"2492\"\u003ePreferential reduction of \u003cstrong data-end=\"2553\" data-start=\"2518\"\u003evisceral (not subcutaneous) fat\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2585\" data-start=\"2554\"\u003e\n\u003cp data-end=\"2585\" data-start=\"2556\"\u003ePreservation of \u003cstrong data-end=\"2585\" data-start=\"2572\"\u003elean mass\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2615\" data-start=\"2586\"\u003e\n\u003cp data-end=\"2615\" data-start=\"2588\"\u003eImproved \u003cstrong data-end=\"2615\" data-start=\"2597\"\u003elipid profiles\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2647\" data-start=\"2616\"\u003e\n\u003cp data-end=\"2647\" data-start=\"2618\"\u003eReduced \u003cstrong data-end=\"2647\" data-start=\"2626\"\u003ehepatic steatosis\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2682\" data-start=\"2648\"\u003e\n\u003cp data-end=\"2682\" data-start=\"2650\"\u003eImproved \u003cstrong data-end=\"2682\" data-start=\"2659\"\u003einsulin sensitivity\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"2750\" data-start=\"2684\"\u003eThis endocrine selectivity is the defining feature of Tesamorelin.\u003c\/p\u003e\n\u003cp data-end=\"2750\" data-start=\"2684\"\u003e \u003c\/p\u003e\n\u003ch2 data-end=\"2784\" data-start=\"2757\"\u003e\u003cstrong data-end=\"2784\" data-start=\"2760\"\u003eKey Research Domains\u003c\/strong\u003e\u003c\/h2\u003e\n\u003ch3 data-end=\"2834\" data-start=\"2786\"\u003e\u003cstrong data-end=\"2834\" data-start=\"2790\"\u003e1. Visceral Adiposity \u0026amp; Body Composition\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-end=\"2950\" data-start=\"2835\"\u003eTesamorelin is most studied for its selective action on \u003cstrong data-end=\"2914\" data-start=\"2891\"\u003evisceral fat depots\u003c\/strong\u003e, making it a reference compound in:\u003c\/p\u003e\n\u003cul data-end=\"3056\" data-start=\"2951\"\u003e\n\u003cli data-end=\"2975\" data-start=\"2951\"\u003e\n\u003cp data-end=\"2975\" data-start=\"2953\"\u003eCentral obesity models\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3015\" data-start=\"2976\"\u003e\n\u003cp data-end=\"3015\" data-start=\"2978\"\u003eHIV-associated lipodystrophy research\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3056\" data-start=\"3016\"\u003e\n\u003cp data-end=\"3056\" data-start=\"3018\"\u003eAge-related fat redistribution studies\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"3126\" data-start=\"3058\"\u003eNotably, reductions occur \u003cstrong data-end=\"3125\" data-start=\"3084\"\u003ewithout significant loss of lean mass\u003c\/strong\u003e.\u003c\/p\u003e\n\u003ch3 data-end=\"3184\" data-start=\"3133\"\u003e\u003cstrong data-end=\"3184\" data-start=\"3137\"\u003e2. Metabolic Syndrome \u0026amp; Insulin Sensitivity\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-end=\"3221\" data-start=\"3185\"\u003eResearch shows Tesamorelin improves:\u003c\/p\u003e\n\u003cul data-end=\"3307\" data-start=\"3222\"\u003e\n\u003cli data-end=\"3253\" data-start=\"3222\"\u003e\n\u003cp data-end=\"3253\" data-start=\"3224\"\u003eInsulin sensitivity (HOMA-IR)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3275\" data-start=\"3254\"\u003e\n\u003cp data-end=\"3275\" data-start=\"3256\"\u003eTriglyceride levels\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3307\" data-start=\"3276\"\u003e\n\u003cp data-end=\"3307\" data-start=\"3278\"\u003eLipoprotein particle profiles\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"3383\" data-start=\"3309\"\u003eThis positions Tesamorelin as a \u003cstrong data-end=\"3365\" data-start=\"3341\"\u003emetabolic normalizer\u003c\/strong\u003e, not a stimulant.\u003c\/p\u003e\n\u003ch3 data-end=\"3437\" data-start=\"3390\"\u003e\u003cstrong data-end=\"3437\" data-start=\"3394\"\u003e3. Lipid \u0026amp; Cardiovascular Risk Research\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-end=\"3467\" data-start=\"3438\"\u003eTesamorelin has demonstrated:\u003c\/p\u003e\n\u003cul data-end=\"3571\" data-start=\"3468\"\u003e\n\u003cli data-end=\"3497\" data-start=\"3468\"\u003e\n\u003cp data-end=\"3497\" data-start=\"3470\"\u003eReductions in triglycerides\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3533\" data-start=\"3498\"\u003e\n\u003cp data-end=\"3533\" data-start=\"3500\"\u003eImprovements in LDL particle size\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3571\" data-start=\"3534\"\u003e\n\u003cp data-end=\"3571\" data-start=\"3536\"\u003eReduced atherogenic lipid fractions\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"3627\" data-start=\"3573\"\u003eFrequently studied in \u003cstrong data-end=\"3626\" data-start=\"3595\"\u003ecardiometabolic risk models\u003c\/strong\u003e.\u003c\/p\u003e\n\u003ch3 data-end=\"3673\" data-start=\"3634\"\u003e\u003cstrong data-end=\"3673\" data-start=\"3638\"\u003e4. Hepatic Fat \u0026amp; NAFLD Research\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-end=\"3721\" data-start=\"3674\"\u003eTesamorelin has shown meaningful reductions in:\u003c\/p\u003e\n\u003cul data-end=\"3772\" data-start=\"3722\"\u003e\n\u003cli data-end=\"3741\" data-start=\"3722\"\u003e\n\u003cp data-end=\"3741\" data-start=\"3724\"\u003eLiver fat content\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3772\" data-start=\"3742\"\u003e\n\u003cp data-end=\"3772\" data-start=\"3744\"\u003eMarkers of hepatic steatosis\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"3865\" data-start=\"3774\"\u003eThis makes it relevant to \u003cstrong data-end=\"3855\" data-start=\"3800\"\u003efatty liver disease and metabolic liver dysfunction\u003c\/strong\u003e research.\u003c\/p\u003e\n\u003cp data-end=\"3865\" data-start=\"3774\"\u003e \u003c\/p\u003e\n\u003ch2 data-end=\"3909\" data-start=\"3872\"\u003e\u003cstrong data-end=\"3909\" data-start=\"3875\"\u003eResearch Context \u0026amp; Comparisons\u003c\/strong\u003e\u003c\/h2\u003e\n\u003ch3 data-end=\"3936\" data-start=\"3911\"\u003e\u003cstrong data-end=\"3936\" data-start=\"3915\"\u003eTesamorelin vs GH\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul data-end=\"4080\" data-start=\"3937\"\u003e\n\u003cli data-end=\"3970\" data-start=\"3937\"\u003e\n\u003cp data-end=\"3970\" data-start=\"3939\"\u003eGH: Direct, continuous exposure\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4080\" data-start=\"3971\"\u003e\n\u003cp data-end=\"4080\" data-start=\"3973\"\u003eTesamorelin: Pulsatile, endogenous stimulation\u003cbr data-end=\"4022\" data-start=\"4019\"\u003e→ \u003cstrong data-end=\"4080\" data-start=\"4024\"\u003eLower proliferative risk, more physiologic signaling\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 data-end=\"4131\" data-start=\"4082\"\u003e\u003cstrong data-end=\"4131\" data-start=\"4086\"\u003eTesamorelin vs GHRPs (Ipamorelin, GHRP-6)\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul data-end=\"4266\" data-start=\"4132\"\u003e\n\u003cli data-end=\"4169\" data-start=\"4132\"\u003e\n\u003cp data-end=\"4169\" data-start=\"4134\"\u003eGHRPs act via \u003cstrong data-end=\"4169\" data-start=\"4148\"\u003eghrelin receptors\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4266\" data-start=\"4170\"\u003e\n\u003cp data-end=\"4266\" data-start=\"4172\"\u003eTesamorelin acts via \u003cstrong data-end=\"4211\" data-start=\"4193\"\u003eGHRH receptors\u003c\/strong\u003e\u003cbr\u003e→ More \u003cstrong data-end=\"4266\" data-start=\"4219\"\u003emetabolic and visceral-fat–specific effects\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch2 data-end=\"4302\" data-start=\"4273\"\u003e\u003cstrong data-end=\"4302\" data-start=\"4276\"\u003eProduct Specifications\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cul data-end=\"4719\" data-start=\"4304\"\u003e\n\u003cli data-end=\"4347\" data-start=\"4304\"\u003e\n\u003cp data-end=\"4347\" data-start=\"4306\"\u003e\u003cstrong data-end=\"4324\" data-start=\"4306\"\u003eCompound Name:\u003c\/strong\u003e Tesamorelin (TH9507)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4383\" data-start=\"4348\"\u003e\n\u003cp data-end=\"4383\" data-start=\"4350\"\u003e\u003cstrong data-end=\"4365\" data-start=\"4350\"\u003eCAS Number:\u003c\/strong\u003e 218949-48-5\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4429\" data-start=\"4384\"\u003e\n\u003cp data-end=\"4429\" data-start=\"4386\"\u003e\u003cstrong data-end=\"4408\" data-start=\"4386\"\u003eMolecular Formula: \u003c\/strong\u003eC₂₂₁H₃₆₆N₇₂O₆₇S\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4470\" data-start=\"4430\"\u003e\n\u003cp data-end=\"4470\" data-start=\"4432\"\u003e\u003cstrong data-end=\"4453\" data-start=\"4432\"\u003eMolecular Weight:\u003c\/strong\u003e 5,135.86 Da\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4509\" data-start=\"4471\"\u003e\n\u003cp data-end=\"4509\" data-start=\"4473\"\u003e\u003cstrong data-end=\"4492\" data-start=\"4473\"\u003ePeptide Length:\u003c\/strong\u003e 29 amino acids\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4544\" data-start=\"4510\"\u003e\n\u003cp data-end=\"4544\" data-start=\"4512\"\u003e\u003cstrong data-end=\"4530\" data-start=\"4512\"\u003ePeptide Class:\u003c\/strong\u003e GHRH analog\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4581\" data-start=\"4545\"\u003e\n\u003cp data-end=\"4581\" data-start=\"4547\"\u003e\u003cstrong data-end=\"4558\" data-start=\"4547\"\u003ePurity:\u003c\/strong\u003e ≥98% (HPLC verified)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4614\" data-start=\"4582\"\u003e\n\u003cp data-end=\"4614\" data-start=\"4584\"\u003e\u003cstrong data-end=\"4593\" data-start=\"4584\"\u003eForm:\u003c\/strong\u003e Lyophilized powder\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4659\" data-start=\"4615\"\u003e\n\u003cp data-end=\"4659\" data-start=\"4617\"\u003e\u003cstrong data-end=\"4632\" data-start=\"4617\"\u003eAppearance:\u003c\/strong\u003e White to off-white solid\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4719\" data-start=\"4660\"\u003e\n\u003cp data-end=\"4719\" data-start=\"4662\"\u003e\u003cstrong data-end=\"4674\" data-start=\"4662\"\u003eStorage:\u003c\/strong\u003e ≤ –20 °C, desiccated, protected from light\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch2 data-end=\"638\" data-start=\"598\"\u003e\u003cstrong data-end=\"636\" data-start=\"598\"\u003eBatch Documentation \u0026amp; Traceability\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp data-end=\"762\" data-start=\"645\"\u003eEach vial is shipped with a \u003cstrong data-end=\"697\" data-start=\"673\"\u003elot-specific QR code\u003c\/strong\u003e that provides secure access to batch documentation, including:\u003c\/p\u003e\n\u003cp data-end=\"891\" data-start=\"769\"\u003e• Certificate of Analysis (COA)\u003cbr data-end=\"803\" data-start=\"800\"\u003e• Identity verification report (HPLC \/ MS)\u003cbr data-end=\"850\" data-start=\"847\"\u003e• Lot number, potency, and expiration\u003c\/p\u003e\n\u003cp data-end=\"1028\" data-start=\"898\"\u003eDocumentation is \u003cstrong data-end=\"955\" data-start=\"915\"\u003elocked to the specific batch shipped\u003c\/strong\u003e to ensure traceability, version control, and research reproducibility.\u003c\/p\u003e\n\u003cp data-end=\"1113\" data-start=\"1035\"\u003eQR access is provided with the physical product and is not reused across lots.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch2 data-end=\"5265\" data-start=\"5235\"\u003e\u003cstrong data-end=\"5265\" data-start=\"5238\"\u003eResearch Use Disclaimer\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp data-end=\"5443\" data-start=\"5266\"\u003eThis product is supplied \u003cstrong data-end=\"5334\" data-start=\"5291\"\u003eexclusively for laboratory research use\u003c\/strong\u003e.\u003cbr data-end=\"5338\" data-start=\"5335\"\u003eNot for human or veterinary use.\u003cbr data-end=\"5373\" data-start=\"5370\"\u003eNot intended for diagnostic, therapeutic, or consumptive applications.\u003c\/p\u003e","brand":"Velora Biolabs","offers":[{"title":"10 mg vial","offer_id":47055888449690,"sku":"VBL-TSM-RS-010","price":39.0,"currency_code":"USD","in_stock":true},{"title":"20 mg Vial","offer_id":48669488906394,"sku":null,"price":79.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0719\/1484\/8410\/files\/TSM10.png?v=1782680204","url":"https:\/\/velorabiolabs.com\/products\/tesamorelin-peptide","provider":"Velora Biolabs","version":"1.0","type":"link"}